United States - English - NLM (National Library of Medicine)

orient pharma co., ltd. - miglitol (unii: 0v5436jaqw) (miglitol - unii:0v5436jaqw) - miglitol 25 mg - miglitol tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. miglitol tablets are contraindicated in patients with: - diabetic ketoacidosis - inflammatory bowel disease, colonic ulceration, or partial intestinal obstruction, and in patients predisposed to intestinal obstruction - chronic intestinal diseases associated with marked disorders of digestion or absorption, or with conditions that may deteriorate as a result of increased gas formation in the intestine - hypersensitivity to the drug or any of its components

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries inc. - miglitol (unii: 0v5436jaqw) (miglitol - unii:0v5436jaqw) - miglitol 25 mg - miglitol tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. miglitol tablets are contraindicated in patients with:

United States - English - NLM (National Library of Medicine)

westminster pharmaceuticals, llc - miglitol (unii: 0v5436jaqw) (miglitol - unii:0v5436jaqw) - miglitol tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. miglitol tablets are contraindicated in patients with: - diabetic ketoacidosis - inflammatory bowel disease, colonic ulceration, or partial intestinal obstruction, and in patients predisposed to intestinal obstruction - chronic intestinal diseases associated with marked disorders of digestion or absorption, or with conditions that may deteriorate as a result of increased gas formation in the intestine - hypersensitivity to the drug or any of its components

United States - English - NLM (National Library of Medicine)

proficient rx lp - miglitol (unii: 0v5436jaqw) (miglitol - unii:0v5436jaqw) - miglitol tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. miglitol tablets are contraindicated in patients with:

United States - English - NLM (National Library of Medicine)

pharmacia & upjohn company llc - miglitol (unii: 0v5436jaqw) (miglitol - unii:0v5436jaqw) - miglitol 25 mg - glyset is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. glyset tablets are contraindicated in patients with: - diabetic ketoacidosis - inflammatory bowel disease, colonic ulceration, or partial intestinal obstruction, and in patients predisposed to intestinal obstruction - chronic intestinal diseases associated with marked disorders of digestion or absorption, or with conditions that may deteriorate as a result of increased gas formation in the intestine - hypersensitivity to the drug or any of its components.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

towa pharmaceutical co., ltd. - miglitol - faintly yellowish white tablet with split line, diameter: 6.5 mm, thickness: 2.5 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

towa pharmaceutical co., ltd. - miglitol - faintly yellowish white tablet with split line, diameter: 8.5 mm, thickness: 3.0 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

towa pharmaceutical co., ltd. - miglitol - faintly yellowish white tablet with split line, diameter: 10.0 mm, thickness: 3.4 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sawai pharmaceutical co.,ltd. - miglitol - white tablet, diameter: 6.5 mm, thickness: 3.5 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sawai pharmaceutical co.,ltd. - miglitol - white tablet, diameter: 8.0 mm, thickness: 3.9 mm